70924 Federal Register / Vol. 65, No. 229 / Tuesday, November 28, 2000 / Notices

Contact Person: Dr. Ellen Feigal, Acting

Executive Secretary, National Cancer

Institute, National Institutes of Health, (301)

496–2522.

Name of Committee: National Cancer

Advisory Board, Ad Hoc Subcommittee on

Communications.

Closed: December 5, 12:20 p.m. to 12:55

p.m.

Agenda: To discuss information of a

proprietary and/or personal nature regarding

the proposed structure of communication

activities within the NCI.

Contact Person: Dr. Susan Sieber,

Executive Secretary, National Cancer

Institute, National Institutes of Health, (301)

496–5946.

Name of Committee: National Cancer

Advisory Board.

Open: December 5, 1:00 p.m. to 4:10 p.m.

Agenda: Program reports and

presentations; Business of the Board. For

detailed agenda: See NCI Homepage/

Advisory Board and Groups, http://

deainfo.nci.nih.gov/ADVISORY/boards.htm.

Tentative agenda available 10 working days

prior to meetings; Final agenda available 5

working days prior to meetings.

Closed: December 5, 4:20 p.m. to Recess.

Agenda: To review and evaluate intramural

research projects and discuss information of

a personal and confidential nature.

Open: December 6, 8:45 a.m. to

Adjournment (About 12:00 p.m.).

Agenda: Program reports and

presentations; Business of the Board. For

detailed agenda: See NCI Homepage/

Advisory Board and Groups, http://

deainfo.nci.nih.gov/ADVISORY/boards.htm.

Tentative agenda available 10 working days

prior to meetings; Final agenda available 5

working days prior to meetings.

Place: Building 31, C Wing, 6 Floor,

Conference Room 10, National Institutes of

Health, 9000 Rockville Pike, Bethesda, MD

20892.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, 8th Floor, Room 8001,

Bethesda, MD 20892–8327, (301) 496–5147.

This meeting is being published less than

15 days prior to the meeting due to

scheduling conflicts.

Dated: November 16, 2000.

Laverne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–30163 Filed 11–27–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Cooperative Planning Grant for

Comprehensive Minority Institution/Cancer

Center Partnership.

Date: December 3, 2000.

Time: 7:00 pm to 10:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, 4300 Military Road,

NW, Chevy Chase, MD 20015.

Contact Person: Rashmi Gopal-Srivastava,

PHD, Scientific Review Administrator, Office

of Advisory Activities, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard/EPN-Room 8078,

Rockville, MD 20892–7410, 301/594–1182.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Planning

Minority Institution/Cancer Center

Collaboration.

Date: December 4, 2000.

Time: 8:00 pm to 4:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, 4300 Military Road,

NW, Chevy Chase, MD 20015.

Contact Person: Rashmi Gopal-Srivastava,

PHD, Scientific Review Administrator, Office

of Advisory Activities, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard/EPN-Room 8078,

Rockville, MD 20892–7410, 301/594–1182.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Cancer

Institute Emphasis Panel, Comprehensive

Minority Institution/Cancer Center

Partnership.

Date: December 4, 2000.

Time: 5:00 pm to 7:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Embassy Suites, 4300 Military Road,

NW, Chevy Chase, MD 20015.

Contact Person: Rashmi Gopal-Srivastava,

PHD, Scientific Review Administrator, Office

of Advisory Activities, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard/EPN-Room 8078,

Rockville, MD 20892–7410, 301/594–1182.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: November 16, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–30168 Filed 11–27–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Initial Review Group, Subcommittee

E—Cancer Epidemiology, Prevention &

Control.

Date: December 6–8, 2000.

Time: 7:30 pm to 12:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn-Georgetown, 2101

Wisconsin Avenue, N.W., Washington, DC

20007.

Contact Person: Mary C. Fletcher, PhD,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6116 Executive

Boulevard, Room 8115, Bethesda, MC 20892–

8238.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.